JP2005503383A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005503383A5 JP2005503383A5 JP2003520752A JP2003520752A JP2005503383A5 JP 2005503383 A5 JP2005503383 A5 JP 2005503383A5 JP 2003520752 A JP2003520752 A JP 2003520752A JP 2003520752 A JP2003520752 A JP 2003520752A JP 2005503383 A5 JP2005503383 A5 JP 2005503383A5
- Authority
- JP
- Japan
- Prior art keywords
- adrenal
- pharmaceutical composition
- hydrocortisone
- disease
- caused
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0119848.0A GB0119848D0 (en) | 2001-08-15 | 2001-08-15 | Delayed and sustained drug release |
| PCT/GB2002/003631 WO2003015793A1 (en) | 2001-08-15 | 2002-08-08 | Delayed and sustained drug release |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005503383A JP2005503383A (ja) | 2005-02-03 |
| JP2005503383A5 true JP2005503383A5 (enExample) | 2006-01-05 |
Family
ID=9920405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003520752A Pending JP2005503383A (ja) | 2001-08-15 | 2002-08-08 | 遅らせかつ持続された薬剤放出 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050037074A1 (enExample) |
| EP (1) | EP1416938A1 (enExample) |
| JP (1) | JP2005503383A (enExample) |
| CA (1) | CA2493349A1 (enExample) |
| GB (1) | GB0119848D0 (enExample) |
| WO (1) | WO2003015793A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0213100A (pt) * | 2001-10-05 | 2004-11-30 | Combinatorx Inc | Combinações para o tratamento de distúrbios imuniinflamatórios |
| TW200517114A (en) * | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
| GB0400031D0 (en) | 2004-01-03 | 2004-02-04 | Univ Sheffield | Depression treatment |
| SE0401031D0 (sv) | 2004-04-22 | 2004-04-22 | Duocort Ab | A new glucocorticoid replacement therapy |
| MX2008014828A (es) * | 2006-05-22 | 2009-02-06 | Combinatorx Inc | Metodos y composiciones para el tratamiento de enfermedades o condiciones asociadas con niveles incrementados de proteina c-reactiva, interleucina-6 o interferon-gamma. |
| GB0623740D0 (en) * | 2006-11-28 | 2007-01-10 | Diurnal Ltd | Treatment of disease |
| CA2737131A1 (en) * | 2007-09-19 | 2009-03-26 | Zalicus Inc. | Therapeutic regimens for the treatment of immunoinflammatory disorders |
| CA2709561A1 (en) * | 2007-12-17 | 2009-06-25 | Combinatorx, Incorporated | Therapeutic regimens for the treatment of immunoinflammatory disorders |
| GB0817120D0 (en) * | 2008-09-19 | 2008-10-29 | Diurnal Ltd | Treatment of adrenal insufficiency |
| NZ595428A (en) * | 2009-04-07 | 2013-04-26 | Duocourt Pharma Ab | Improved glucocorticoid therapy |
| BR112012029466A2 (pt) | 2010-05-20 | 2017-03-01 | Duocort Phama Ab | "composição de glicocorticoide, método melhorado para tratar a deficiência de glicocorticoide, e, método para dar origem a uma dosagem individualizada de glicocorticoides" |
| GB201202433D0 (en) | 2012-02-13 | 2012-03-28 | Diurnal Ltd | Controlled drug release |
| JP6754533B2 (ja) | 2015-03-30 | 2020-09-16 | コーセプト セラピューティクス， インコーポレイテッド | 副腎機能不全を処置するための糖質コルチコイドと組み合わせた糖質コルチコイドレセプターアンタゴニストの使用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5792476A (en) * | 1996-12-19 | 1998-08-11 | Abigo Medical Ab | Sustained release glucocorticoid pharmaceutical composition |
| US5788987A (en) * | 1997-01-29 | 1998-08-04 | Poli Industria Chimica Spa | Methods for treating early morning pathologies |
| DE19718012C1 (de) * | 1997-04-29 | 1998-10-08 | Jenapharm Gmbh | Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe |
| DE10012555A1 (de) * | 2000-03-15 | 2001-09-20 | Merck Patent Gmbh | Glucocorticoide in einer Modified Release-Formulierung |
-
2001
- 2001-08-15 GB GBGB0119848.0A patent/GB0119848D0/en not_active Ceased
-
2002
- 2002-08-08 US US10/486,700 patent/US20050037074A1/en not_active Abandoned
- 2002-08-08 CA CA002493349A patent/CA2493349A1/en not_active Abandoned
- 2002-08-08 EP EP02751394A patent/EP1416938A1/en not_active Withdrawn
- 2002-08-08 JP JP2003520752A patent/JP2005503383A/ja active Pending
- 2002-08-08 WO PCT/GB2002/003631 patent/WO2003015793A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007502287A5 (enExample) | ||
| JP2004210798A5 (enExample) | ||
| HRP20120264T1 (hr) | Farmaceutski sastavi neuroaktivnog steroida i njihove uporabe | |
| JP2006520797A5 (enExample) | ||
| WO2008057420A3 (en) | Extended triterpene derivatives | |
| WO2006135638A3 (en) | Tanaproget compositions containing ethinyl estradiol | |
| JP2005533005A5 (enExample) | ||
| WO2007048219A3 (en) | Sustained drug release composition | |
| ATE493132T1 (de) | Arzneimittel umfassend wenigstens ein gestagen | |
| JP2011506412A5 (enExample) | ||
| TW200635617A (en) | Multiparticulate pharmaceutical form comprising mucoadhesively formulated nucleic acid active ingredients, and a process for producing the pharmaceutical form | |
| EP1571153A3 (en) | A process for the preparation of drospirenone | |
| JP2010539153A5 (enExample) | ||
| WO2005011614A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease | |
| WO2005077968A8 (en) | 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity | |
| SE0200895D0 (sv) | New pharmaceutical composition | |
| US11266646B2 (en) | Use of chymase inhibitors for the treatment of endometriosis, post operative fibrosis and diseases which are characterized by fibrosis formation | |
| JP2008534533A5 (enExample) | ||
| JP2008515980A5 (enExample) | ||
| WO2005011604A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease | |
| WO2007062483A8 (en) | Increasing pregnancy rates | |
| WO2005011595A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease | |
| WO2007007282A3 (en) | Azabicyclo derivatives as muscarinic receptor antagonists | |
| WO2005011616A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease | |
| JP2007505157A5 (enExample) |